Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06031129
Status:
COMPLETED
Last Update Posted:
2023-09-11
First Post:
2023-08-29
Brief Title:
Butorphanol in Pain Following Ablation for Hepatic Tumor
Sponsor:
Bibo Wang
Organization:
Jinling Hospital China
Study Overview
Official Title:
Effectiveness of Butorphanol in Alleviating Postoperative Visceral Pain Following Microwave Ablation for Hepatic Tumor A Multicentral Randomized Placebo-Controlled Trial
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this investigation was to evaluate the influence of Butorphanol on postoperative pain mitigation in patients undergoing microwave ablation for hepatic tumor Employing a rigorously designed multicentral randomized and placebo-controlled format patients subjected to microwave ablation were assigned randomly to either Butorphanol experimental group or normal saline control group Primary outcomes encompassed intraoperative pain levels assessed through patient-driven evaluation utilizing a 10-point visual analog scale VAS Secondary outcomes included postoperative pain levels at the 6-hour mark VAS and comprehensive pain assessment outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None